Virios Therapeutics, Inc. (VIRI)
USD 0.16
(12.4%)
USD 0.16
(12.4%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
| Operating Expenses | 5.44 Million | 12.31 Million | 15.64 Million | 10 Million | 2.17 Million | 1.96 Million |
| Selling, General and Administrative Expenses | 3.71 Million | 4.24 Million | 4.84 Million | 9.81 Million | 1.34 Million | 1.1 Million |
| Research and Development Expenses | 1.72 Million | 8.06 Million | 10.79 Million | 194.01 Thousand | 836.17 Thousand | 854.1 Thousand |
| Other Expenses | - | 67.47 Thousand | -319.32 Thousand | -341 Thousand | - | 6.00 |
| Cost and Expenses | 5.44 Million | 12.31 Million | 15.64 Million | 10 Million | 2.17 Million | 1.96 Million |
| Operating Income | -5.44 Million | -12.31 Million | -15.64 Million | -10 Million | -2.17 Million | -1.96 Million |
| Interest Expense | - | - | 5672.00 | 384.22 Thousand | 295.12 Thousand | 152.1 Thousand |
| Income Tax Expense | -5446.92 | -67.47 Thousand | -15.64 Thousand | -10 Thousand | 295.12 Thousand | 152.1 Thousand |
| Earnings before Tax | -5.29 Million | -12.24 Million | -15.96 Million | -10.34 Million | -2.47 Million | -2.11 Million |
| Net Income | -5.29 Million | -12.18 Million | -15.96 Million | -10.34 Million | -2.76 Million | -2.11 Million |
| Earnings Per Share Basic | -0.28 | -1.10 | -1.92 | -1.25 | -0.33 | -0.44 |
| Earnings Per Share Diluted | -0.28 | -1.10 | -1.92 | -1.25 | -0.33 | -0.44 |
| Weighted Average Shares Outstanding | 18.77 Million | 11.07 Million | 8.32 Million | 8.3 Million | 8.28 Million | 4.83 Million |
| Weighted Average Shares Outstanding (Diluted) | 18.77 Million | 11.07 Million | 8.32 Million | 8.3 Million | 8.28 Million | 4.83 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | 150.9 Thousand | -12.31 Million | -15.64 Million | -10 Million | -295.12 Thousand | -152.09 Thousand |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
| Operating Expenses | 1.06 Million | 1.31 Million | 5.44 Million | 1.13 Million | 1.27 Million | 1.47 Million |
| Selling, General and Administrative Expenses | 733.74 Thousand | 970.38 Thousand | - | 839.8 Thousand | 900.08 Thousand | 919.37 Thousand |
| Research and Development Expenses | 336.08 Thousand | 343.71 Thousand | - | 298.32 Thousand | 374.2 Thousand | 557.84 Thousand |
| Other Expenses | - | - | - | -115.95 Thousand | 39.21 Thousand | 36.31 Thousand |
| Cost and Expenses | 1.06 Million | 1.31 Million | 5.44 Million | 1.13 Million | 1.27 Million | 1.47 Million |
| Operating Income | -1.06 Million | -1.31 Million | -5.44 Million | -1.13 Million | -1.27 Million | -1.47 Million |
| Interest Expense | - | - | - | 40.42 Thousand | - | - |
| Income Tax Expense | 4.00 | -1.31 Million | -5446.92 | 41.9 Thousand | -1274.29 | -1477.22 |
| Earnings before Tax | -1.04 Million | -1.29 Million | -5.29 Million | -1.1 Million | -1.23 Million | -1.44 Million |
| Net Income | -1.04 Million | -1.29 Million | -5.29 Million | -1.1 Million | -1.23 Million | -1.44 Million |
| Earnings Per Share Basic | -0.05 | -0.07 | - | -0.06 | -0.06 | -0.08 |
| Earnings Per Share Diluted | -0.05 | -0.07 | - | -0.06 | -0.06 | -0.08 |
| Weighted Average Shares Outstanding | 22.9 Million | 19.25 Million | 18.77 Million | 19.25 Million | 19.09 Million | 18.41 Million |
| Weighted Average Shares Outstanding (Diluted) | 22.9 Million | 19.25 Million | 18.77 Million | 19.25 Million | 19.09 Million | 18.41 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -1.06 Million | -1.31 Million | - | -1.13 Million | -1.27 Million | -1.47 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
DODLA
SAF
SCVPF
MDXH
KAST
TXO